Data gathered: April 19
Alternative Data for IQVIA
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1,838 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 1,346,000 | Sign up | Sign up | Sign up |
| Employee Rating | 76 | Sign up | Sign up | Sign up |
| Google Trends | 74 | Sign up | Sign up | Sign up |
| Patents | 119 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 121 | Sign up | Sign up | Sign up |
| Facebook Followers | 65,932 | Sign up | Sign up | Sign up |
| Instagram Followers | 21,669 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,093 | Sign up | Sign up | Sign up |
| Twitter Followers | 17,328 | Sign up | Sign up | Sign up |
| Twitter Mentions | 11 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 68 | Sign up | Sign up | Sign up |
| Linkedin Employees | 78,236 | Sign up | Sign up | Sign up |
About IQVIA
North Carolina-based IQVIA Holdings, Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry. The company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
| Price | $143.91 |
| Target Price | Sign up |
| Volume | 3,300,000 |
| Market Cap | $25.4B |
| Year Range | $143.22 - $251.55 |
| Dividend Yield | 0% |
| PE Ratio | 19.24 |
| Analyst Rating | 85% buy |
| Industry | Biotechnology |
In the news
IQVIA Holdings Inc. stock outperforms competitors despite losses on the dayApril 15 - MarketWatch |
|
 |
Stabilization and improvement seen in multiple key biopharma R&D metrics, says IQVIA Institute ReportApril 14 - Yahoo |
IQVIA Holdings Inc. stock outperforms competitors on strong trading dayApril 14 - MarketWatch |
|
 |
IQVIA Holdings Inc. (NYSE:IQV) Shares Bought by Wellington Management Group LLPApril 13 - ETF Daily News |
 |
Truist Financial Has Lowered Expectations for IQVIA (NYSE:IQV) Stock PriceApril 12 - ETF Daily News |
|
IQVIA (NYSE:IQV) Earns “Equal Weight” Rating from BarclaysApril 12 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 3.9B | 3.07B | 915M | 285M | 798M | 2.840 |
| Q2 '24 | 3.81B | 3.03B | 863M | 363M | 817M | 2.640 |
| Q1 '24 | 3.57B | 2.97B | 827M | 288M | 767M | 2.540 |
| Q4 '23 | 3.68B | 4.03B | -1.06B | 469M | 844M | 2.840 |
| Q3 '23 | 3.56B | 2.96B | 862M | 303M | 857M | 2.490 |
Insider Transactions View All
| DANHAKL JOHN G filed to buy 1,275 shares at $200.6. February 7 '25 |
| Sherbet Eric filed to sell 19,536 shares at $246.3. August 29 '24 |
| BOUSBIB ARI filed to sell 796,752 shares at $251. March 4 '24 |
| BOUSBIB ARI filed to sell 812,169 shares at $250.1. March 4 '24 |
| STAUB W RICHARD filed to sell 15,945 shares at $249.1. March 4 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rob Bresnahan |
Mar 28, 25 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
Jun 5, 24 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
May 6, 24 | Buy | $1K - $15K |
Read more about IQVIA (IQV) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of IQVIA?
The Market Cap of IQVIA is $25.4B.
What is IQVIA's PE Ratio?
As of today, IQVIA's PE (Price to Earnings) ratio is 19.24.
What is the current stock price of IQVIA?
Currently, the price of one share of IQVIA stock is $143.91.
How can I analyze the IQV stock price chart for investment decisions?
The IQV stock price chart above provides a comprehensive visual representation of IQVIA's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling IQVIA shares. Our platform offers an up-to-date IQV stock price chart, along with technical data analysis and alternative data insights.
Does IQV offer dividends to its shareholders?
As of our latest update, IQVIA (IQV) does not offer dividends to its shareholders. Investors interested in IQVIA should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of IQVIA?
Some of the similar stocks of IQVIA are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.